Respiratory Rehabilitation and Sleep Quality in COPD Patients

Recruiting N/A Interventional Study
COPD (Chronic Obstructive Pulmonary Disease)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
90 (estimated)
Sponsor
University Hospital, Rouen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
COPD affects 5 to 8% of the population in France. The disease consists of inflammation of the large and small airways causing permanent obstruction of the airways and symptoms such as dyspnea, cough and sputum that worsens over time. Among all COPD patients, 40% complain of sleep disorders. Polysomnography data showed a prolongation of sleep onset latency and a decrease in deep sleep, correlated …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Male or female ≥ age 50 * COPD defined according to the GOLD 2022 criteria, clinically stable (without exacerbation for at least 4 weeks), with indication for respiratory rehabilitation * Absence of respiratory rehabilitation in the past 12 months * Patient affiliated to the s…
Contacts

Marie-Anne Melone, MD, PhD

(+33) 0232888265

marieanne.melone@chu-rouen.fr

CONTACT